About 8,060 results

ALLMedicine™ Community-acquired Pneumonia Center

Research & Reviews  2,376 results

Susceptibility of Ceftobiprole against Gram-positive and Gram-negative Clinical Isolate...
Journal of Global Antimicrobial Resistance; Hawser S, Kothari N et. al.

May 14th, 2022 - Ceftobiprole is approved for use in treatment of hospital-associated and community-acquired pneumonia in 16 different European countries and is currently undergoing clinical trials in the USA. Isolates were collected from hospital laboratories fro...

Community-acquired Pseudomonas aeruginosa pneumonia manifested by bloody pleural effusi...
Journal of Clinical Laboratory Analysis; Dong C, Shen F et. al.

May 14th, 2022 - Community-acquired Pseudomonas aeruginosa pneumonia in immunocompetent children is a rare occurrence. A retrospective analysis of the clinical manifestations, imaging characteristics, laboratory examinations, and treatment of a child with communit...

Radiographic Imaging of Community-Acquired Pneumonia: A Case-Based Review.
Radiologic Clinics of North America; Washington L, O'Sullivan-Murphy B et. al.

May 10th, 2022 - The chest radiograph is the most common imaging examination performed in most radiology departments, and one of the more common indications for these studies is suspected infection. Radiologists must therefore be aware of less common radiographic ...

Denosumab and risk of community-acquired pneumonia: A population-based cohort study.
The Journal of Clinical Endocrinology and Metabolism; Lyu H, Zhao S et. al.

May 6th, 2022 - Recent meta-analyses of randomized controlled trials raised concerns that denosumab might increase the risk of infection. However, data of denosumab on the risk of community-acquired pneumonia is sparse. To examine the risk of community-acquired p...

see more →

Guidelines  8 results

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice ...
Annals of Internal Medicine; Lee RA, Centor RM et. al.

Apr 6th, 2021 - Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chro...

Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19...
Annals of Internal Medicine; Metlay JP, Waterer GW

May 8th, 2020 - Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic.|2020|Metlay JP,Waterer GW,|epidemiology,therapy,epidemiology,therapy,epidemiology,epidemiology,microbiology,therapy,epidemiology,

ACR Appropriateness Criteria® Pneumonia in the Immunocompetent Child.
Journal of the American College of Radiology : JACR; , Chan SS et. al.

May 7th, 2020 - Pneumonia is one of the most common acute infections and the single greatest infectious cause of death in children worldwide. In uncomplicated, community-acquired pneumonia in immunocompetent patients, the diagnosis is clinical and imaging has no ...

Diagnosis and Treatment of Adults With Community-Acquired Pneumonia.
JAMA Olson G, Davis AM

Feb 7th, 2020 - Diagnosis and Treatment of Adults With Community-Acquired Pneumonia.|2020|Olson G,Davis AM,|drug therapy,adverse effects,therapeutic use,therapeutic use,drug therapy,drug effects,therapeutic use,

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinic...
American Journal of Respiratory and Critical Care Medicine; Metlay JP, Waterer GW et. al.

Oct 2nd, 2019 - Background: This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia.Methods: A multidisciplinary panel conducted pragmatic systematic reviews of the relevant research...

see more →

Drugs  363 results see all →

Clinicaltrials.gov  70 results

Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia

May 6th, 2022 - There is no consensus on the optimal ventilatory management of patients with community-acquired pneumonia that require mechanical ventilation and have acute respiratory distress syndrome. The traditional ventilatory approach (ARDSNet) is based on ...

Modulation of Steroid Immunosuppression by Alveolar Efferocytosis

May 3rd, 2022 - Treating chronic obstructive pulmonary disease (COPD) patients with inhaled glucocorticosteroids has been convincingly shown to increase their risk of pneumonia, but the responsible mechanisms are undefined. Work from this laboratory suggests a po...

Postural Drainage and PEP Technique in Community Acquired Pneumonia

May 2nd, 2022 - Community-acquired pneumonia is acquired outside the hospital. Postural drainage is the positioning of a patient with an involved lung segment such that gravity has a maximal effect of facilitating the drainage of Broncho-pulmonary secretions from...

Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia

Apr 29th, 2022 - An observational study to document the antibiotic treatment rate of children hospitalized for community acquired pneumonia at a pediatric department with longstanding practice of restrictive antibiotic prescribing. Patients will be enrolled consec...

Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia

Apr 28th, 2022 - Coronavirus-2019 disease (COVID-19) and community-acquired pneumonia are significant problems of modern medicine. Pneumonia is the most common severe complication of COVID-19. But at the same time, COVID-19 is not the only cause of community-acqui...

see more →

News  404 results

CDC Details Deadly Aromatherapy Outbreak

Mar 2nd, 2022 - While the lavender-scented spritz from Walmart might have seemed the furthest thing from exotic, the Burkholderia pseudomallei bacteria inside sparked a deadly melioidosis outbreak that CDC scientists highlighted as a reason to watch for unexpecte...

Early Flu Treatment of Hospital CAP Patients Improves Outcomes

Feb 17th, 2022 - Early initiation of the antiviral oseltamivir (Tamiflu) reduces the risk for death in patients hospitalized with community-acquired pneumonia (CAP) but patients have to be tested for influenza first and that is not happening often enough, a large ...

Pediatric Community-Acquired Pneumonia: 5 Days of Antibiotics Better Than 10 Days

Jan 19th, 2022 - The evidence is in: Less is more when it comes to treating uncomplicated community-acquired pneumonia (CAP) in young children. Five days of antibiotic therapy resulted in a superior clinical response compared to 10 days of treatment and had the ad...

Pneumonia in Infancy Predicts Respiratory Problems in Early Childhood

Jan 5th, 2022 - Preschoolers who experienced community-acquired pneumonia in infancy were significantly more likely than those with no history of pneumonia to develop chronic respiratory disorders, based on data from approximately 7000 individuals. “Lower respira...

Not all patients with community-acquired pneumonia respond to adjunctive dexamethasone

Dec 25th, 2021 - Key clinical point: Neutrophil count, white blood cell (WBC) count, or neutrophil -lymphocyte ratio (NLR) may help in ascertaining which patients hospitalized for community-acquired pneumonia (CAP) would benefit from adjunctive oral dexamethasone.

see more →

Patient Education  3 results see all →